Frontlight ResearchEarly access
Diabetic eye disease trials in United States
39 of 47 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleFaricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
- Where
- Atlanta, Augusta, Austin, Baltimore, Bellaire, Boston, Carmel, Chapel Hill, Chicago, Dallas, Edmond, Houston, Huntington Beach, Indianapolis, Jacksonville, Lakeland, Lexington, Loma Linda, Lubbock, Monroeville, Oak Park, Orlando, Overland, Rochester, Saint Louis Park, Sandy Springs, San Francisco, Santa Barbara, St Louis, Tampa, West Des Moines, West Monroe
- Age
- 18 years and over
- People
- 426
- Run by
- Jaeb Center for Health Research
See details and how to joinNCT06790784 - Early phase 1Enrolling by invitationTreating Early Stage Diabetic Retinopathy
- Where
- Decatur
- Age
- 30 years to 80 years
- People
- 244
- Run by
- VA Office of Research and Development
See details and how to joinNCT05132660 - Phase 1/2Taking peopleA Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
- Where
- Arcadia, Austin, Bellaire, Beverly Hills, Cleveland, Eugene, Falls Church, Fargo, Fort Myers, Glendale, Huntington Beach, Lakeland, McAllen, Nashville, Oceanside, Oxnard, Phoenix, Portland, Sacramento, San Antonio, Scottsdale, Stuart, The Woodlands, Wake Forest, Walnut Creek, Waterford, Willow Park
- Age
- 18 years and over
- People
- 49 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07553429 - Phase 2Taking peopleA Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
- Where
- ‘Aiea, Austin, Bakersfield, Beverly Hills, Campbell, Cleveland, Encino, Glendale, Great Neck, Hagerstown, Huntington Beach, Jacksonville, Katy, Ladson, Lakeland, Lakewood, Liverpool, McAllen, Nashville, Palo Alto, Pasadena, Phoenix, Portland, Round Rock, Sacramento, Salt Lake City, San Antonio, Santa Maria, Schertz, Southaven, Stuart, Teaneck, Walnut Creek, Waterford, Winter Haven
- Age
- 18 years and over
- People
- 175 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06321302 · EU 2023-508891-12-00 - Phase 2Taking peopleA Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
- Where
- Arcadia, Augusta, Austin, Beaumont, Carmel, Charleston, Cleveland, Dallas, Danbury, Eugene, Fort Lauderdale, Fort Worth, Greenville, Hagerstown, Huntington Beach, Jacksonville, Kansas City, Lakewood, Lynchburg, Modesto, Nashville, Newport Beach, Pasadena, Phoenix, Pompano Beach, Poway, Reno, San Antonio, San Francisco, Southaven, Southlake, Stuart, The Woodlands, Wake Forest, Winter Haven
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06962839 · EU 2024-520384-14-00 - Phase 3Taking peopleA Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
- Where
- Asheville, Austin, Bellaire, Bloomfield, Bluffton, Carmel, Charleston, Cherry Hill, Cincinnati, Denver, Florence, Gainesville, Gilbert, Glendale, Hagerstown, Hixson, Johnson City, Knoxville, Lenexa, Lynchburg, Madison, Manchester, Mt. Pleasant, Palm Beach Gardens, Plano, Rochester, Sacramento, San Marcos, Schertz, Springfield, Tampa, The Woodlands, Towson, Wake Forest, West Columbia, Wildwood
- Age
- 18 years and over
- People
- 960 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07705555 · EU 2026-526790-42-01 - Phase 3Taking peopleA Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
- Where
- Aiken, Arlington, Bakersfield, Beaufort, Beverly Hills, Carmel, Charleston, Fort Worth, Greenville, Hagerstown, Hickory, Katy, Ladson, Liverpool, Long Beach, Modesto, Orlando, Phoenix, Sacramento, San Antonio, Southlake, St. Petersburg, Waterford, West Des Moines, Winston-Salem, Winter Haven
- Age
- 18 years and over
- People
- 1,104 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07705607 · EU 2026-526787-20-00 - Phase 3Taking peopleA Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).
- Where
- Abilene, Asheville, Aurora, Austin, Bethlehem, Bloomfield, Bluffton, Carmel, Cary, Charleston, Chevy Chase, Colorado Springs, Dallas, Durango, Edison, Edmund, Elmhurst, Encino, Fairfax, Fort Lauderdale, Fullerton, Greenwich, Hagerstown, Houston, Huntington Beach, Katy, Lemont, Lynchburg, Madison, Middleburg Heights, Nashville, New York, Oak Park, Orlando, Pensacola, Philadelphia, Plantation, Portland, Rapid City, Reno, Sacramento, San Diego, San Mateo, Scottsdale, Southaven, Springfield, St Louis, Tampa, The Woodlands, Tyler, Wake Forest, Walnut Creek, Waterford, Wausau, Westbury
- Age
- 18 years and over
- People
- 514 worldwide
- Run by
- 4D Molecular Therapeutics
See details and how to joinNCT07867080 - Phase 1Taking peopleA Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)
- Where
- Abilene, Austin, Baltimore, Beverly Hills, Erie, Germantown, Lynchburg, Peoria, Philadelphia, San Antonio, St. Petersburg, Walnut Creek
- Age
- 18 years and over
- People
- 93
- Run by
- Genentech, Inc.
See details and how to joinNCT07425522 - Phase 1Taking peopleA Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy
- Where
- Columbus, Glendale, Oak Forest, San Antonio
- Age
- 18 years and over
- People
- 30
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07588100 - No phaseTaking peopleImplementing AI-based Glaucoma Screening Within Federally Qualified Health Centers
- Where
- Birmingham
- Age
- 18 years and over
- People
- 1,800
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT06629649 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO
- Where
- Amarillo, Arlington, Austin, Bakersfield, Beaufort, Bellaire, Bellevue, Cary, Charleston, Elmhurst, Fort Lauderdale, Fort Worth, Glendale, Greensboro, Hagerstown, Hauppauge, Hickory, Katy, Ladson, Lynchburg, Madison, Modesto, Mt. Pleasant, Oxnard, Pasadena, Plano, Redlands, Rochester, Round Rock, Sacramento, Saint Louis Park, San Antonio, Schertz, Scottsdale, Sioux Falls, St. Petersburg, The Woodlands, Wake Forest, Waterford, West Columbia, Winston-Salem, Winter Haven
- Age
- 18 years and over
- People
- 910 worldwide
- Run by
- Kodiak Sciences Inc
See details and how to joinNCT07734844 - Phase 2/3Taking peopleSurabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
- Where
- Augusta, Austin, Bakersfield, Bellaire, Beverly Hills, Bloomfield, Burleson, Campbell, Charleston, Chicago, Dallas, Durango, Encino, Hagerstown, Lakeland, Lakewood, Lemont, Lenexa, Longmont, Mesa, Middleburg Heights, Mountain View, Norfolk, Orlando, Pasadena, Pensacola, Phoenix, Portland, Poway, Reno, Sacramento, Salem, San Francisco, Santa Barbara, Scottsdale, Springfield, Torrance, Walnut Creek
- Age
- 18 years and over
- People
- 576 worldwide
- Run by
- AbbVie
See details and how to joinNCT07592273 - Phase 2Taking peopleA Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular Edema
- Where
- Abilene, Austin, Bakersfield, Cary, Fort Myers, Glendale, Houston, Ladson, Laredo, McAllen, Mountain View, San Antonio, South Miami, The Woodlands, Wake Forest, West Monroe
- Age
- 18 years to 75 years
- People
- 180
- Run by
- BioAge Labs, Inc.
See details and how to joinNCT07812090 - Phase 4Taking peopleLongitudinal Study of Retinal Function in Eyes Treated for Diabetic Macular Edema With Anti-VEGF Agents
- Where
- Augusta, Beaumont, Boston, Detroit, Huntington Beach, Monroeville, Rochester, Sewickley
- Age
- 18 years and over
- People
- 100
- Run by
- Jaeb Center for Health Research
See details and how to joinNCT07567833 - Phase 4Not yet taking people in United StatesIopidine to Decrease Intraocular Pressure Rise After Injections
- Where
- Easton
- Age
- 18 years and over
- People
- 120
- Run by
- Retina Consultants of Delmarva
See details and how to joinNCT07891910 - No phaseTaking peopleLeveraging Artificial Intelligence to Prevent Vision Loss From Diabetes
- Where
- Madison
- Age
- 22 years and over
- People
- 6,900
- Run by
- University of Wisconsin, Madison
See details and how to joinNCT06763952 - Phase 1Taking peopleSafety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Exosomes for NAION
- Where
- Naples
- People
- 20 worldwide
- Run by
- The Foundation for Orthopaedics and Regenerative Medicine
See details and how to joinNCT05147701 - Phase 4Not yet taking people in United StatesContinuous Delivery of Ranibizumab Via the Port Delivery System for Proliferative Diabetic Retinopathy-related Vitreous Hemorrhage With Pars Plana Vitrectomy and Limited PRP.
- Where
- Augusta
- Age
- 18 years and over
- People
- 20
- Run by
- Southeast Retina Center, Georgia
See details and how to joinNCT07864480 - Phase 2Taking peopleLactiplantibacillus Plantarum 299v Probiotic Supplementation in Patients With Diabetic Macular Edema
- Where
- Boston
- Age
- 18 years and over
- People
- 36
- Run by
- Massachusetts Eye and Ear Infirmary
See details and how to joinNCT07383701 - Phase 4Taking peopleCorticosteroid for Diabetic Macular Edema (DME) Study
- Where
- Nashville
- Age
- 18 years and over
- People
- 20
- Run by
- Vanderbilt University Medical Center
See details and how to joinNCT07843849 - No phaseTaking peopleACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
- Where
- Baltimore
- Age
- 8 years to 21 years
- People
- 500
- Run by
- Johns Hopkins University
See details and how to joinNCT05463289 - No phaseTaking peopleClinical Applications of Advanced Ophthalmic Imaging
- Where
- Miami
- Age
- 18 years to 99 years
- People
- 5,000
- Run by
- University of Miami
See details and how to joinNCT03135327 - Phase 1Taking peoplePhase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
- Where
- Bellaire, Deerfield Beach, Erie, La Crosse, Southlake
- Age
- 18 years and over
- People
- 24
- Run by
- Ocugen
See details and how to joinNCT05802329 - No phaseNot yet taking people in United StatesVideo Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma Center
- Where
- San Francisco
- Age
- 18 years and over
- People
- 150
- Run by
- University of California, San Francisco
See details and how to joinNCT07519707